COMPARISON OF CLINICAL OUTCOMES AND PARENTAL SATISFACTION BETWEEN ZIRCONIA AND COMPOSITE STRIP CROWNS IN CHILDREN WITH DECAYED PRIMARY INCISORS: A SYSTEMATIC REVIEW AND META-ANALYSIS.

J Evid Based Dent PractJun 14, 2026 (epub)
Clinical ResearchPediatrics

Mawada Abdelmagied, Susan Parekh, Paul Ashley

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis compared zirconia and composite strip crowns for restoring decayed primary incisors in children. The study included eight randomized controlled trials and one non-randomized prospective study. Zirconia crowns showed significantly better gingival health, lower restoration failure rates, and higher crown retention, with an odds ratio of 7.549 for retention compared to composite crowns.

Key findings

  • Zirconia crowns had significantly higher odds of crown retention (OR 7.549) compared to composite strip crowns.
  • Restoration failure was significantly lower for zirconia crowns (OR 0.158).
  • Zirconia crowns demonstrated better gingival health and lower plaque accumulation.
  • Parental satisfaction tended to favor zirconia crowns, though results were uncertain.

Why it matters

Understanding the comparative effectiveness of zirconia versus composite strip crowns is crucial for pediatric dentists in making informed decisions about restorative options for primary incisors, impacting both clinical outcomes and parental satisfaction.

Source

Published in J Evid Based Dent Pract. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.